HongKong:2607

ImmVira and Shanghai Pharma Announce Clinical Collaboration and License Agreement for Commercialization of Novel Intratumoral Oncolytic Virus Immunotherapies

SHENZHEN and SHANGHAI, August 6, 2020 /PRNewswire/ -- ImmVira Group Company and Shanghai Pharmaceuticals Holding Co., Ltd today announced a clinical collaboration and exclusive license agreement for ImmVira's MVR-T3011 intratumoral oncolytic virus program for the commercialization of novel immun...

2020-08-06 23:49 9371

Shanghai Pharma Global Standard Stock Incentive Scheme to Push Innovation Refiled for Approval

SHANGHAI, Sept. 30, 2019 /PRNewswire/ -- Shanghai Pharmaceuticals Holding Co., Ltd. (Shanghai Pharma) (Hong Kong Stock Exchange: 2607) (Shanghai Stock Exchange: 601607) has launched a new stock incentive plan (the Plan) aligned with international standards aimed at retaining and attracting talent...

2019-10-01 04:00 8218

Shanghai Pharma Unveils Stock Incentive Plans to Accelerate Global Ambition

SHANGHAI, April 15, 2019 /PRNewswire/ -- Shanghai Pharmaceuticals Holdings Co. Ltd. (Shanghai Pharma or "the Company") (601607.SH) (2067.HK), a major Chinese pharmaceutical group, has unveiled stock option incentive plans in a milestone move designed to accelerate restructuring and boost global c...

2019-04-15 20:00 6653

Bracco Imaging and Shanghai Pharmaceuticals join forces in the field of ultrasound

MILAN, May 22, 2018 /PRNewswire/ -- Bracco Imaging S.p.A., a global leader in diagnostic imaging, and Shanghai Pharmaceuticals Holding Co. Ltd., a leading pharmaceutical group inChina - focused on providing innovative drugs in the field of oncology, infectious and cardiovascular diseases - have s...

2018-05-22 20:09 1626

Shanghai Pharmaceuticals Achieves Rapid Business Growth for 3Q2014; Realized Double-Digit Growth of Revenue and Profit

HONG KONG, Oct. 29, 2014 /PRNewswire/ --Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group; stock code: 601607.SH; 2607.HK), the integrated pharmaceutical company in the PRC that has leading positions in both ph...

2014-10-29 21:51 3077

Shanghai Pharmaceuticals Achieves Double-Digit Growth of Revenue and Profit for 1H2014

HONG KONG, Aug. 30, 2014 /PRNewswire/ -- Shanghai Pharmaceuticals Holding Co., Ltd.("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group; stock code: 601607.SH; 2607.HK), the integrated pharmaceutical company in the PRC that has leading positions in both ph...

2014-08-30 00:07 3036

Shanghai Pharmaceuticals Records a Growth of 8.6% in Operating Revenue in 1Q2014

HONG KONG, April 28, 2014 /PRNewswire/ -- Shanghai Pharmaceuticals Holding Co. Ltd., ("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group"; stock code: 601607.SH; 2607.HK), the integrated pharmaceutical company in the PRC that has leading positions in both pha...

2014-04-28 22:45 1236

Maintained Steady Growth Results, Confirmed 3-Year Development Plan, Shanghai Pharmaceuticals Achieved over 15% Growth in Operating Income in 1H2013

HONG KONG, Aug. 23, 2013 /PRNewswire/ -- Shanghai Pharmaceuticals Holding Co. Ltd., ("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group"; stock code: 601607.SH; 02607.HK), today announced its interim results for the first half of 2013. In the first half of 20...

2013-08-23 10:33 5009

Shanghai Pharmaceuticals Joins hands with the Secondary Military Medical University to Explore the New Medicine R&D and Translational Medicine Field

HONG KONG, July 31, 2013 /PRNewswire/ -- Nowadays, Translational Medicine has become the buzzword in the field of pharmaceutical research and development. To jointly promote the development of this emerging field of research, Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai Pharmaceuticals" or ...

2013-07-31 21:21 1387

Shanghai Pharmaceuticals Announces 1st Quarterly Results of 2013

-- Operating Revenue Surges 17.6% -- Change of Board of Directors On Schedule HONG KONG, April 29, 2013 /PRNewswire/ -- Shanghai Pharmaceuticals Holding Co. Ltd., ("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group"; stock code: 601607.SH; 02607.HK), to...

2013-04-29 08:00 2541

Shanghai Pharmaceuticals Announces 2012 Third Quarterly Report

Operating Revenue & Net Profit Attributable to Shareholders of the Parent Company Surges 27.01% & 12.15% respectively HONG KONG, Oct. 29, 2012 /PRNewswire/ -- Shanghai Pharmaceuticals Holding Co. Ltd., ("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group"; ...

2012-10-29 23:39 1477

Shanghai Pharmaceuticals Group Calls AGM Adjust Use of Proceeds & Strengthen Core Business

HONG KONG, May 31, 2012 /PRNewswire-Asia/ -- Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai Pharmaceuticals Group" or the "Company" and, together with its subsidiaries, the "Group; stock code: 601607.SH; 2607.HK), today called its 2011 annual general meeting (AGM). The number of attendees rea...

2012-05-31 23:43 3236

Week's Top Stories